Howell SJ - Search Results

1

A novel preclinical model of the normal human breast.

Wilby AJ, Cabral S, Zoghi N, Howell SJ, Farnie G, Harrison H. Wilby AJ, et al. Among authors: howell sj. J Mammary Gland Biol Neoplasia. 2024 May 2;29(1):9. doi: 10.1007/s10911-024-09562-4. J Mammary Gland Biol Neoplasia. 2024. PMID: 38695983 Free PMC article.

2

Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.

Howell SJ, Anderson E, Hunter T, Farnie G, Clarke RB. Howell SJ, et al. Breast Cancer Res. 2008;10(4):R68. doi: 10.1186/bcr2129. Epub 2008 Aug 5. Breast Cancer Res. 2008. PMID: 18681966 Free PMC article.

3

Are stem-like cells responsible for resistance to therapy in breast cancer?

O'Brien CS, Farnie G, Howell SJ, Clarke RB. O'Brien CS, et al. Among authors: howell sj. Breast Dis. 2008;29:83-9. doi: 10.3233/bd-2008-29109. Breast Dis. 2008. PMID: 19029627 No abstract available.

4

Resistance to endocrine therapy: are breast cancer stem cells the culprits?

O'Brien CS, Howell SJ, Farnie G, Clarke RB. O'Brien CS, et al. Among authors: howell sj. J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):45-54. doi: 10.1007/s10911-009-9115-y. Epub 2009 Feb 28. J Mammary Gland Biol Neoplasia. 2009. PMID: 19252972 Review.

5

Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB. Harrison H, et al. Among authors: howell sj. Cancer Res. 2010 Jan 15;70(2):709-18. doi: 10.1158/0008-5472.CAN-09-1681. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068161 Free PMC article.

6

Breast cancer stem cells and their role in resistance to endocrine therapy.

O'Brien CS, Farnie G, Howell SJ, Clarke RB. O'Brien CS, et al. Among authors: howell sj. Horm Cancer. 2011 Apr;2(2):91-103. doi: 10.1007/s12672-011-0066-6. Horm Cancer. 2011. PMID: 21761332 Free PMC article. Review.

7

Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.

Singh JK, Farnie G, Bundred NJ, Simões BM, Shergill A, Landberg G, Howell SJ, Clarke RB. Singh JK, et al. Among authors: howell sj. Clin Cancer Res. 2013 Feb 1;19(3):643-56. doi: 10.1158/1078-0432.CCR-12-1063. Epub 2012 Nov 13. Clin Cancer Res. 2013. PMID: 23149820 Free PMC article.

8

Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.

Harrison H, Simões BM, Rogerson L, Howell SJ, Landberg G, Clarke RB. Harrison H, et al. Among authors: howell sj. Breast Cancer Res. 2013 Mar 8;15(2):R21. doi: 10.1186/bcr3396. Breast Cancer Res. 2013. PMID: 23497505 Free PMC article.

9

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

Singh JK, Simões BM, Howell SJ, Farnie G, Clarke RB. Singh JK, et al. Among authors: howell sj. Breast Cancer Res. 2013;15(4):210. doi: 10.1186/bcr3436. Breast Cancer Res. 2013. PMID: 24041156 Free PMC article. Review.

10

Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.

Simões BM, O'Brien CS, Eyre R, Silva A, Yu L, Sarmiento-Castro A, Alférez DG, Spence K, Santiago-Gómez A, Chemi F, Acar A, Gandhi A, Howell A, Brennan K, Rydén L, Catalano S, Andó S, Gee J, Ucar A, Sims AH, Marangoni E, Farnie G, Landberg G, Howell SJ, Clarke RB. Simões BM, et al. Among authors: howell sj, howell a. Cell Rep. 2015 Sep 29;12(12):1968-77. doi: 10.1016/j.celrep.2015.08.050. Epub 2015 Sep 17. Cell Rep. 2015. PMID: 26387946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters